Your browser doesn't support javascript.
loading
Microwave assisted synthesis of negative-charge carbon dots with potential antibacterial activity against multi-drug resistant bacteria.
Kung, Jung-Chang; Tseng, I-Ting; Chien, Chi-Sheng; Lin, Sheng-Hui; Wang, Chun-Chi; Shih, Chi-Jen.
Afiliação
  • Kung JC; School of Dentistry, College of Dental Medicine, Kaohsiung Medical University Kaohsiung Taiwan.
  • Tseng IT; Department of Dentistry, Division of Family Dentistry, Kaohsiung Medical University Hospital Kaohsiung Taiwan.
  • Chien CS; Drug Development and Value Creation Research Center, Kaohsiung Medical University Kaohsiung Taiwan.
  • Lin SH; Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University 100 Shi-Chuan 1st Road Kaohsiung 80708 Taiwan cjshih@gap.kmu.edu.tw +886 73121101 ext. 2367.
  • Wang CC; Department of Orthopedics, Chi Mei Medical Center Tainan Taiwan.
  • Shih CJ; Department of Electrical Engineering, Southern Taiwan University of Science and Technology Tainan Taiwan.
RSC Adv ; 10(67): 41202-41208, 2020 Nov 09.
Article em En | MEDLINE | ID: mdl-35519222
ABSTRACT
In this research, negative-charge carbon dots (CDs) were synthesized in one-step using a microwave and found to have potential antibacterial ability against multi-drug resistant bacteria. The CDs were synthesized by using citric acid and urea as precursors, and characterized by FT-IR, TEM and fluorescence spectrophotometry. The average size of CDs was about 2.5 nm, and the ζ potential was -11.06 mV. In the following antibacterial activity test, time-killing curve experiments and colony-forming assay were carried out to determine the minimum bactericidal concentration (MBC) and minimum inhibitory concentration (MIC) of the CDs against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-intermediate Staphylococcus aureus (VISA). The data showed the MBC of the CDs against MRSA is 2.5 mg mL-1, and the MIC of the CDs against MRSA is 0.63 mg mL-1; the MBC of the CDs against VISA is 1.25 mg mL-1, and the MIC of the CDs against VISA is 0.63 mg mL-1. The results demonstrated that the negative-charge CDs have potential against multi-drug resistant Staphylococcus aureus (S. aureus), and may serve as alternatives for therapy in the future.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article